Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajwinder Lehal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Development (Cambridge, England)|January 31, 2013
Stem cells living with a NotchUte Koch, Rajwinder Lehal, Freddy Radtke
Chimia|October 29, 2020
Notch Inhibition in Cancer: Challenges and OpportunitiesDoriano Fabbro, Michael Bauer, Maximilien Murone, et al.
Genesis (New York, N.Y. : 2000)|April 11, 2012
Generation and characterization of a Notch1 signaling-specific reporter mouse lineEmma Smith, Stéphanie Claudinot, Rajwinder Lehal, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Cancers|August 12, 2023
The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast CancerMichele Vigolo, Charlotte Urech, Sebastien Lamy, et al.
Nature Communications|August 3, 2013
Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD productionMitko Dimitrov, Jean-René Alattia, Thomas Lemmin, et al.
British Journal of Haematology|December 9, 2022
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103Filippo Spriano, Chiara Tarantelli, Alberto J Arribas, et al.
Oral Oncology|August 24, 2023
Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry stainingKaran Patel, Massimiliano Manzo, Brindley Hapuarachi, et al.
Cancer Research|August 5, 2021
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut ToxicityHayley M Sabol, Adam J Ferrari, Manish Adhikari, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Pharmacological disruption of the Notch transcription factor complexRajwinder Lehal, Jelena Zaric, Michele Vigolo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Development (Cambridge, England)|January 31, 2013
Stem cells living with a NotchUte Koch, Rajwinder Lehal, Freddy Radtke
Chimia|October 29, 2020
Notch Inhibition in Cancer: Challenges and OpportunitiesDoriano Fabbro, Michael Bauer, Maximilien Murone, et al.
Genesis (New York, N.Y. : 2000)|April 11, 2012
Generation and characterization of a Notch1 signaling-specific reporter mouse lineEmma Smith, Stéphanie Claudinot, Rajwinder Lehal, et al.
Ejhaem|September 2, 2022
CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALLMichael Medinger, Till Junker, Dominik Heim, et al.
Cancers|August 12, 2023
The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast CancerMichele Vigolo, Charlotte Urech, Sebastien Lamy, et al.
Nature Communications|August 3, 2013
Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD productionMitko Dimitrov, Jean-René Alattia, Thomas Lemmin, et al.
British Journal of Haematology|December 9, 2022
In vitro anti-lymphoma activity of the first-in-class pan-NOTCH transcription inhibitor CB-103Filippo Spriano, Chiara Tarantelli, Alberto J Arribas, et al.
Oral Oncology|August 24, 2023
Gene expression patterns in adenoid cystic carcinoma with and without diffuse NOTCH1 intracellular domain (NICD1) immunohistochemistry stainingKaran Patel, Massimiliano Manzo, Brindley Hapuarachi, et al.
Cancer Research|August 5, 2021
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut ToxicityHayley M Sabol, Adam J Ferrari, Manish Adhikari, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
Pharmacological disruption of the Notch transcription factor complexRajwinder Lehal, Jelena Zaric, Michele Vigolo, et al.
Pageof 1